Many hoping for another pump and run with CANB. Most would really like to break even here and run as fast as possible.
Will be hard as the CBD isolate products are coming so fast that many of these will not be able to stay in business as CBD isolate is becoming so dirt cheap.
Looks like everyone in the US jumped in this in some way and there will be so much CBD isolate that many will be forced out or to lose money selling products.
Canbiola has been growing in revenue and assets, reducing liability and growing through acquisitions and creation of its subsidiaries. While expenses are high, revenue growth will outpace those expenses in the near term.
Like yourself and many others, I am also optimistic about this company. It doesn't need to be perfect, the value is its potential.
Here is the true makeup of Canb, and the reason it has exceeded with triple digit growth, and over $1 million in revenue in the first two Quarters of this year:
Duramed provides wearable bioelectronic devices for the delivery of sustained acoustic medicine (SAMs). The proprietary miniaturized ultrasound platform is designed for the treatment of acute and chronic musculoskeletal conditions, and clinically proven to enhance tissue recovery, accelerate the natural healing processes, and relieve pain. The SAM® family of products are the only FDA-cleared wearable devices for multi-hour continuous low intensity ultrasound therapy.
Duramed also provide the Mobius Therapy Device, a revolutionary new system that combines powerful botanical extracts with modern science and technology to deliver Endless Relief from many types of pain.
Combining the pain-relief and anti-inflammatory benefits of CBD based medication with Transcutaneous Electrical Nerve Stimulation (TENS), a proven medical technology successfully used by doctors, hospitals and physiotherapists for over 50 years and is now available for over-the-counter use, is what makes Mobius Therapy so unique. Mobius Therapy Device is registered with the FDA as a Class II Medical Device.
“The use of therapeutic ultrasound to treat a variety of conditions offers great promise to our patients. In particular, Duramed products represent a breakthrough in our abilities to treat patients in a user friendly, convenient manner.” Dr. Thomas M. Best, MD, PhD, Director or Sports Medicine, University of Miami
NY Hemp Depot LLC https://www.sec.gov/Archives/edgar/data/1509957/000149315219010762/form8-k.htm Pursuant to the Agreement, NY – SHI agreed to provide (i) technical expertise regarding the growth and cultivation of industrial hemp, (ii) certain products that may include feminized hemp seeds and/or clone plants to sell to the Farmers, (iii) growing technology and expertise to grow, cultivate, and harvest industrial hemp, including the initial training of Farmers to grow industrial hemp and maximize CBD potency, (iv) use of its cultivating license, which shall be amended to add a New York hemp depot facility (the “NY Hemp Depot Facility”) once such facility is obtained by Canbiola Sub, and (v) services for the recruitment of Farmers to grow and cultivate industrial hemp for sale to the Joint Venture.
Pure Health Products https://www.sec.gov/Archives/edgar/data/1509957/000149315219009362/ex99-1_031.jpg "Canbiola, Inc. has recently (January 2019) completed the acquisition of Pure Health Products LLC including the laboratory and production facility located outside Seattle Washington. The facility is a full-on development laboratory and a fully integrated production facility whereby all formulations, processes, and materials are vertically integrated in the production process. There are no third-party vendors and the company controls the process at each step of processing to insure 100% quality control and product purity. Additionally, all the automated processing and packaging equipment are wholly owned, and the company has no debt."
News 
Market Data 
Discover 
AI
